[go: up one dir, main page]

MXPA02005559A - Proteinas de tcr de alta afinidad y metodos. - Google Patents

Proteinas de tcr de alta afinidad y metodos.

Info

Publication number
MXPA02005559A
MXPA02005559A MXPA02005559A MXPA02005559A MXPA02005559A MX PA02005559 A MXPA02005559 A MX PA02005559A MX PA02005559 A MXPA02005559 A MX PA02005559A MX PA02005559 A MXPA02005559 A MX PA02005559A MX PA02005559 A MXPA02005559 A MX PA02005559A
Authority
MX
Mexico
Prior art keywords
cell receptor
coding sequence
tcrs
high affinity
methods
Prior art date
Application number
MXPA02005559A
Other languages
English (en)
Inventor
D Holler Phillip
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of MXPA02005559A publication Critical patent/MXPA02005559A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)

Abstract

Se proporcionan los receptores de celulas T (TCR) que tienen afinidad superior para el ligando que los TCR del tipo silvestre. Se forman estos TCR de alta afinidad por mutagenizar una secuencia de codificacion de proteina del receptor de celulas T para generar una poblacion variada de mutantes de la secuencia de codificacion de proteina del receptor de celulas T; transformar la secuencia de codificacion mutante del receptor de celulas T dentro de celulas de levaduras; inducir la expresion de la secuencia de codificacion mutante del receptor de celulas T en la superficie de celulas de levaduras; y seleccionar aquellas celulas que expresan mutantes del receptor de celulas T que tienen afinidad superior para el ligando de peptido/MHC que la proteina del receptor de celulas T del tipo silvestre. Los TCR de alta afinidad pueden ser usados en lugar de un anticuerpo o anticuerpo de cadena sencilla.
MXPA02005559A 1999-12-06 2000-12-06 Proteinas de tcr de alta afinidad y metodos. MXPA02005559A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16917999P 1999-12-06 1999-12-06
PCT/US2000/042622 WO2001048145A2 (en) 1999-12-06 2000-12-06 High affinity tcr proteins and methods

Publications (1)

Publication Number Publication Date
MXPA02005559A true MXPA02005559A (es) 2004-09-10

Family

ID=22614526

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA02005559A MXPA02005559A (es) 1999-12-06 2000-12-06 Proteinas de tcr de alta afinidad y metodos.
MX2012000116A MX340559B (es) 1999-12-06 2000-12-06 Proteinas de tcr de alta afinidad y metodos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2012000116A MX340559B (es) 1999-12-06 2000-12-06 Proteinas de tcr de alta afinidad y metodos.

Country Status (9)

Country Link
EP (4) EP1247095B1 (es)
JP (4) JP4972264B2 (es)
AT (1) ATE411522T1 (es)
AU (1) AU5076301A (es)
CA (1) CA2406668C (es)
DE (1) DE60040556D1 (es)
DK (1) DK1247095T3 (es)
MX (2) MXPA02005559A (es)
WO (1) WO2001048145A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
AU2002220275A1 (en) * 2000-12-08 2002-06-18 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
EP2075256A2 (en) 2002-01-14 2009-07-01 William Herman Multispecific binding molecules
AU2003304374A1 (en) * 2002-08-29 2005-02-14 Baylor College Of Medicine Peptide inhibitors of beta-lactamases
CN1901839A (zh) * 2003-11-10 2007-01-24 阿尔特生物科学公司 可溶性tcr分子及其用途
ES2320374T3 (es) 2005-01-05 2009-05-21 F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H. Dominios de inmunoglobulina sintetica con propiedades de enlace modificadas en regiones de la molecula diferentes de las regiones de determinacion de complementariedad.
WO2006097110A2 (en) * 2005-03-18 2006-09-21 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
US7534762B2 (en) 2005-03-18 2009-05-19 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
RU2403260C2 (ru) * 2005-03-18 2010-11-10 Новозимс Эдениум Байотек А/С Полипептиды, обладающие противомикробным действием, и кодирующие их полинуклеотиды
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
AT503861B1 (de) * 2006-07-05 2008-06-15 F Star Biotech Forsch & Entw Verfahren zur manipulation von t-zell-rezeptoren
JP5602625B2 (ja) 2007-06-26 2014-10-08 エフ−スター ビオテヒノロギッシェ フォルシュングス− ウント エントヴィッケルングスゲゼルシャフト ミット ベシュレンクテル ハフツング 結合物質のディスプレイ
EP2113255A1 (en) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Cytotoxic immunoglobulin
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
SG11201507928QA (en) 2013-03-28 2015-10-29 Medicago Inc Influenza virus-like particle production in plants
WO2015103704A1 (en) 2014-01-10 2015-07-16 Medicago Inc. Cpmv enhancer elements
RU2722696C2 (ru) 2014-03-14 2020-06-03 Иммунокор Лимитед Библиотеки tcr
CA2943796C (en) 2014-03-27 2023-02-14 Medicago Inc. Modified cpmv enhancer elements
GB201516265D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516269D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516275D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516272D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516277D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR libraries
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
GB201604953D0 (en) 2016-03-23 2016-05-04 Immunocore Ltd T cell receptors
KR102473964B1 (ko) 2016-04-08 2022-12-06 이뮤노코어 리미티드 T 세포 수용체
GB201709866D0 (en) 2017-06-20 2017-08-02 Immunocore Ltd T cell receptors
CN109777778B (zh) * 2017-11-14 2023-07-18 中国科学院广州生物医药与健康研究院 一种基因改造的γδT细胞
EP3747456A4 (en) * 2018-01-31 2021-12-01 Tohoku University PROCESS FOR REGULATING THE EXPRESSION OF THE SPECIFIC MHC OF AN ANTIGEN
US20220275043A1 (en) 2018-07-17 2022-09-01 Massachusetts Institute Of Technology Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
GB201904328D0 (en) 2019-03-28 2019-05-15 Immunocore Ltd Specific binding molecules
US20210032370A1 (en) 2019-08-02 2021-02-04 Immatics Biotechnologies Gmbh Recruiting agent further binding an mhc molecule
DE102019121007A1 (de) 2019-08-02 2021-02-04 Immatics Biotechnologies Gmbh Antigenbindende Proteine, die spezifisch an MAGE-A binden
US12480958B2 (en) 2019-08-13 2025-11-25 Immatics Biotechnologies Gmbh Method for the characterization of peptide:MHC binding polypeptides
GB201915282D0 (en) 2019-10-22 2019-12-04 Immunocore Ltd Specific binding molecules
US20230132241A1 (en) 2020-01-15 2023-04-27 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding prame
GB202006629D0 (en) 2020-05-05 2020-06-17 Immunocore Ltd Specific binding molecules
GB202010329D0 (en) 2020-07-06 2020-08-19 Immunocore Ltd Specific binding molecules
WO2022184805A1 (en) 2021-03-03 2022-09-09 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
WO2022233956A1 (en) 2021-05-05 2022-11-10 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding prame
JP2024529467A (ja) 2021-07-27 2024-08-06 イマティクス バイオテクノロジーズ ゲーエムベーハー Ｃｔ４５に特異的に結合する抗原結合タンパク質
JP2025508738A (ja) 2022-02-20 2025-04-10 イムノコア リミテッド Ｈｉｖ特異的結合分子及びｔｃｒ
AR130241A1 (es) 2022-08-18 2024-11-20 Immunocore Ltd Receptores de linfocitos t y proteínas de fusión de estos
TW202434640A (zh) 2023-01-06 2024-09-01 英商英美偌科有限公司 結合分子
AU2024206446A1 (en) 2023-01-06 2025-07-10 Immunocore Limited Binding molecules against a piwil1 peptide-hla complex
GB202306345D0 (en) 2023-04-28 2023-06-14 Immunocore Ltd Binding molecules

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3927193A (en) 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4361544A (en) 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4444744A (en) 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US4348376A (en) 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4468457A (en) 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
US5101827A (en) 1985-07-05 1992-04-07 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4640561A (en) 1985-11-15 1987-02-03 Ford Motor Company Flexible printed circuit connector
US5059413A (en) 1988-04-18 1991-10-22 Xoma Corporation Scintigraphic monitoring of immunotoxins using radionuclides and heterobifunctional chelators
ES2125854T3 (es) 1989-08-09 1999-03-16 Rhomed Inc Radiomarcado directo de anticuerpos y otras proteinas con tecnetio o renio.
US5299253A (en) 1992-04-10 1994-03-29 Akzo N.V. Alignment system to overlay abdominal computer aided tomography and magnetic resonance anatomy with single photon emission tomography
US5861156A (en) * 1993-01-08 1999-01-19 Creative Biomolecules Methods of delivering agents to target cells
US6300065B1 (en) * 1996-05-31 2001-10-09 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
AU6685698A (en) * 1997-03-07 1998-09-22 Sunol Molecular Corporation Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor

Also Published As

Publication number Publication date
WO2001048145A3 (en) 2002-01-10
EP2287185A2 (en) 2011-02-23
EP2042869A3 (en) 2009-06-17
CA2406668A1 (en) 2001-07-05
ATE411522T1 (de) 2008-10-15
EP1247095B1 (en) 2008-10-15
EP2336775A2 (en) 2011-06-22
DE60040556D1 (de) 2008-11-27
CA2406668C (en) 2015-11-24
JP2011101649A (ja) 2011-05-26
EP1247095A2 (en) 2002-10-09
JP2003518377A (ja) 2003-06-10
EP2042869B1 (en) 2017-10-04
JP2012065672A (ja) 2012-04-05
JP2014095722A (ja) 2014-05-22
JP4972264B2 (ja) 2012-07-11
EP2042869A2 (en) 2009-04-01
EP1247095A4 (en) 2003-04-02
MX340559B (es) 2016-07-14
AU5076301A (en) 2001-07-09
EP2287185A3 (en) 2012-10-10
DK1247095T3 (da) 2008-12-08
EP2336775A3 (en) 2013-03-20
WO2001048145A2 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
MX340559B (es) Proteinas de tcr de alta afinidad y metodos.
EP2360265A3 (en) Yeast cell surface display of proteins and uses thereof
AU6597998A (en) HLA-A2.1 binding peptides and their uses
HUP9802538A2 (hu) Vektorok és eljárások helyspecifikus rekombináció előidézésére
CY2586B2 (en) Modulators of the function of FAS/APO1 receptors
AU6195398A (en) HLA binding peptides and their uses
EP1526141A3 (en) MHC complexes and uses thereof
DK0669929T3 (da) Elk-ligand, et cytokin
EP0149548A3 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
WO1996009386A3 (en) Allelic variation of the serotonin 5ht2c receptor
EP1019546A4 (en) LYMPHOCYTAL FUNCTION MEASUREMENT TECHNIQUES
MX9802730A (es) Agonistas receptores hematopoyeticos multifuncionales.
AU7832394A (en) Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
AU6412098A (en) Methods for identifying cell cycle regulators
WO1996040939A3 (en) Expression of functional vertebrate phospholipases in yeast
Halstensen et al. In situ two-and three-color immunofluorescence staining of mucosal T-cells in celiac disease. Increase of TCR gamma/delta+ CD8-and TCR alpha/beta+ CD45R0+ intraepithelial lymphocytes and IL-2R+ TCR alpha/beta+ CD4+ CD45R0+ lamina propria lymphocytes
WO1998054223A3 (en) Immunological method
AU696454B2 (en) Family of peptides known as xenoxins
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
Wcislo A false antithesis and evolutionary psychology
Kazuko et al. Studies on gramicidin S synthetase. Purification of the heavy enzyme obtained from some mutants of Bacillus brevis.: Purification of the Heavy Enzyme Obtained from Some Mutants of Bacillus brevis
MX9700213A (es) Citocina novedosa designada como lerk-5.
RU93004705A (ru) Олигосахариды, фармацевтическая композиция, применение олигосахаридов

Legal Events

Date Code Title Description
FG Grant or registration